Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Alexion Pharmaceuticals, Inc.    ALXN

Delayed Quote. Delayed  - 04/29 09:59:55 pm
139.28 USD   -2.28%
04/28 Sanofi launches $9.3 billion fight for U.S. cancer firm Medivatio..
04/28DJALEXION PHARMAC : Profit Declines but Revenue Rises
04/28DJALEXION PHARMAC : Profit Declines but Revenue Rises
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/25/2016 04/26/2016 04/27/2016 04/28/2016 04/29/2016 Date
158.02(c) 154.01(c) 150.78(c) 142.53(c) 139.28(c) Last
849 052 1 458 572 1 865 581 3 278 627 2 042 791 Volume
-0.68% -2.54% -2.10% -5.47% -2.28% Change
More quotes
Financials ($)
Sales 2016 3 068 M
EBIT 2016 1 300 M
Net income 2016 710 M
Debt 2016 1 594 M
Yield 2016 -
Sales 2017 3 767 M
EBIT 2017 1 714 M
Net income 2017 1 101 M
Debt 2017 522 M
Yield 2017 -
P/E ratio 2016 45,27
P/E ratio 2017 28,86
EV / Sales 2016 10,7x
EV / Sales 2017 8,45x
Capitalization 31 297 M
More Financials
Company
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, engages in the innovation, development, and commercialization of life-transforming therapeutic products for treating patients with severe and ultra-rare disorders.It focuses on developing products for the treatment of diseases in the... 
Sector
Pharmaceuticals
Calendar
05/11Shareholder meeting
More about the company
Surperformance© ratings of Alexion Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Latest news on ALEXION PHARMACEUTICALS, I
04/28 ALEXION PHARMACEUTICALS INC : Results of Operations and Financial Condition, Fin..
04/28 Sanofi launches $9.3 billion fight for U.S. cancer firm Medivation
04/28DJALEXION PHARMACEUTICALS : Profit Declines but Revenue Rises
04/28DJALEXION PHARMACEUTICALS : Profit Declines but Revenue Rises
04/28 ALEXION PHARMACEUTICALS : misses Street 1Q forecasts
04/28 ALEXION PHARMACEUTICALS : Reports First Quarter 2016 Results
04/25ALEXION PHARMACEUTICALS, INC. : quaterly earnings release
04/12 ALEXION PHARMACEUTICALS : to Report First Quarter 2016 Results on Thursday, Apri..
More news
Sector news : Biopharmaceuticals
04/30 Buffett, Munger slam Valeant; drugmaker turned into 'a sewer'
04/30 ABBVIE : Galapagos and AbbVie expand their cystic fibrosis collaboration
04/30 SANOFI : Zealand reports Lyxumia royalty revenue for Q1 2016 and submission by S..
More sector news : Biopharmaceuticals
News from SeekingAlpha
04/29 Healthcare ratings roundup
04/29 BIOTECH FORUM DAILY DIGEST : M&A Picks Up, Gilead Finally Disappoints! Spotlight..
04/29 Alexion Pharmaceuticals (ALXN) David L. Hallal on Q1 2016 Results - Earnings ..
04/28 Alexion reports Q1 results, updates guidance
04/28 Alexion Pharmaceuticals (ALXN) Q1 2016 Results - Earnings Call Webcast


Comments 
Advertisement
Chart ALEXION PHARMACEUTICALS, I
Duration : Period :
Alexion Pharmaceuticals, I Technical Analysis Chart | ALXN | US0153511094 | 4-Traders
Full-screen chart
Technical analysis trends ALEXION PHARMACEU...
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions